In support of the link between pathologic modifications to tau and development of POCD, animal studies have shown that modulation of tau pathology using transgenic approaches or pharmacological approaches may decrease the risk of cognitive impairment following anesthesia and surgery [98, 99]. The gene discussed is MAPT; the disease is Cognitive impairment.